Virus News and Research

Latest Virus News and Research

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

A study conducted by US-based scientists claims that bivalent mRNA booster vaccines do not have any added benefits over monovalent booster vaccines in terms of inducing robust and durable neutralizing antibody response against omicron subvariants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Feb 2023

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

Scientists at The University of Queensland have developed a novel vaccine for Japanese encephalitis virus (JEV) in pigs, to help stop the spread of the disease in Australia.

15 Feb 2023

"AutoPLP" technique enables rapid, accurate detection of mutating bacteria and viruses

As we now know from our experience with the COVID-19 pandemic, the microbes responsible for some infections can rapidly mutate into variants that evade detection and treatment.

15 Feb 2023

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins rapidly spreading throughout the body.

15 Feb 2023

Study: Organ damage persists in 59% of COVID patients a year after initial symptoms

A new comprehensive study of organ impairment in long COVID patients over twelve months shows organ damage persisted in 59% of patients a year after initial symptoms, even in those not severely affected when first diagnosed with the virus.

15 Feb 2023

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

The National Institutes of Health has initiated a multi-site clinical trial evaluating an investigational antiviral for the treatment of COVID-19.

15 Feb 2023

Scientists reach a substantial consensus on the four principles that will enable the future development and expansion of virus taxonomy

A team of 45 virologists, evolutionary biologists, bioinformaticians, and structural biologists from around the world arrived at a consensus on virus classification methodologies and presented an integrated taxonomical framework for the systematics and taxonomy of viruses.

15 Feb 2023

Study finds RSV responsible for most infant hospitalizations in the European Union

In a recent study posted to the medRxiv* preprint server, researchers used statistical modeling to estimate hospitalizations due to respiratory syncytial virus (RSV) infections in children under five years of age in 28 nations of the European Union (EU) and Norway.

15 Feb 2023

Aerosol experts provide an account of the rejection of aerosol science by the WHO

In a recent viewpoint article published in the journal Clinical Infectious Diseases, researchers underscored the need for prompt adoption of scientific evidence, using the delayed acceptance of the airborne mode of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission as an example.

15 Feb 2023

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

In a recent study posted to the bioRxiv* preprint server, researchers identified a novel antiviral pathway different from the interferon (IFN) pathway that inhibited poxvirus(es) replication.

15 Feb 2023

New insights into the role of T-cells during long COVID

Researchers characterize the trajectory of long COVID in patients eight months after recovering from infection.

14 Feb 2023

Fibromyalgia may occur post-COVID

Researchers investigate the incidence of fibromyalgia among individuals hospitalized due to SARS-CoV-2 infection.

14 Feb 2023

New mouse model demonstrates clear differences in virulence among mpox virus clades

Scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health have removed a major roadblock to better understanding of mpox (formerly, monkeypox).

14 Feb 2023

Complete genomics drops genome sequencing price to sub $100 at AGBT General Meetin

Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

From MGI 14 Feb 2023

Omicron variant of SARS-CoV-2 is less infectious in dogs and cats

Researchers assess the susceptibility of cats and dogs to the SARS-CoV-2 Omicron variant.

13 Feb 2023

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

A recent study examines the neutralization of SARS-CoV-2 Omicron sub-variants by sera from boosted individuals and those with breakthrough infection.

13 Feb 2023

Influenza A virus suppresses SARS-CoV-2 replication during co-infection

SARS-CoV-2 does not suppress the replication of influenza A in simultaneous or sequential co-infections.

13 Feb 2023

Researchers uncover the cellular basis for sex-specific differences in COVID-19 patients

COVID-19 has had a huge global impact since the initial outbreak in 2019. Men and women show different responses to this disease, with men having a higher risk from infection.

13 Feb 2023

Paxlovid can prevent hospitalization and death for patients infected with Omicron variants, study shows

Though many Coloradans are proceeding as though the COVID-19 pandemic is over, the virus continues to circulate, evolve and have an impact - especially for older adults and those with underlying medical conditions.

13 Feb 2023

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

Researchers developed spherical hydrogel inhalation for enhanced lung defense to protect against SARS-CoV-2 infections.

13 Feb 2023

Virus News and Research

Latest Virus News and Research

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

Novel vaccine to stop the spread of Japanese encephalitis virus in pigs

"AutoPLP" technique enables rapid, accurate detection of mutating bacteria and viruses

Promising HIV vaccine candidate by Texas Biomed stops the virus upon entry

Study: Organ damage persists in 59% of COVID patients a year after initial symptoms

NIH initiates a clinical trial evaluating an investigational antiviral for treatment of COVID-19

Scientists reach a substantial consensus on the four principles that will enable the future development and expansion of virus taxonomy

Study finds RSV responsible for most infant hospitalizations in the European Union

Aerosol experts provide an account of the rejection of aerosol science by the WHO

Study finds a new mammalian antiviral response pathway restricting poxviruses replication

New insights into the role of T-cells during long COVID

Fibromyalgia may occur post-COVID

New mouse model demonstrates clear differences in virulence among mpox virus clades

Complete genomics drops genome sequencing price to sub $100 at AGBT General Meetin

Omicron variant of SARS-CoV-2 is less infectious in dogs and cats

Omicron BQ and XBB subvariants most resistant viruses to monoclonal antibodies

Influenza A virus suppresses SARS-CoV-2 replication during co-infection

Researchers uncover the cellular basis for sex-specific differences in COVID-19 patients

Paxlovid can prevent hospitalization and death for patients infected with Omicron variants, study shows

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in